Lucas Franki
News
USPSTF issues draft research plan on opioid use disorder prevention
December 17, 2018
Public comment is sought on the research plan.
News
FDA approves sufentanil for adults with acute pain
November 2, 2018
The opioid is to used for only adult patients in settings that are closely controlled.
News
FDA clears Abbott’s Influenza A & B 2, Strep A 2 assays
October 25, 2018
The Influenza A & B 2 assay can detect and differentiate influenza A and B in 13 minutes, while the Strep A 2 assay detects group A streptococcus bacterial nucleic acid in 6 minutes.
News
FDA approves Xofluza for treatment of influenza
October 24, 2018
The FDA has approved Xofluza for acute uncomplicated influenza in people aged 12 years or older who have been symptomatic for 48 hours or less.
News
CDC warns of hepatitis A outbreaks in injection drug users
June 11, 2018
Gap in vaccine availability now has been solved.
News
Thrombectomy shines in presence of a clinical deficit and imaging mismatch
January 3, 2018
Less disability, greater functional independence, and less neurologic deterioration was observed for thrombectomy plus standard care.
News
Sepsis response team does not improve mortality/organ dysfunction
October 23, 2017
A sepsis response team did not have a positive effect on mortality or organ dysfunction in septic patients, compared with standard treatment by a primary care team, according to a study abstract scheduled to be presented at CHEST 2017.[[{"fid":"206723","view_mode":"medstat_image_full_text","fiel...
News
Rapid genomic testing can diagnose critically ill infants
September 25, 2017
Rapid, targeted genomic sequencing shows promise in quickly diagnosing critically ill infants for whom standard clinical work-ups were unsuccessful.
News
FDA approves first spironolactone oral suspension
August 9, 2017
After more than 50 years on the U.S. market, spironolactone is available in liquid form, bypassing the compounding pharmacist.
News
FDA approves betrixaban for VTE prophylaxis
June 23, 2017
An orally administered agent has been approved for VTE prophylaxis in at risk hospitalized patients.